No. of patiens (%) | VATS (n = 114) | Thoracotomy (n = 46) | p | |
---|---|---|---|---|
Gender | 0.002 | |||
Male | 84(52.5) | 51 | 33 | |
Female | 76(47.5) | 63 | 13 | |
Age | 0.1001 | |||
≤70 | 85(53.1) | 58 | 27 | |
> | 75(46.9) | 56 | 19 | |
Pathology | 0.1533 | |||
Adenocarcinoma | 123(769) | 91 | 31 | |
Squamous cell ca. | 28(17.5) | 17 | 11 | |
Large cell ca. | 3(1.9) | 3 | 0 | |
Others | 6(3.7) | 3 | 3 | |
Tumor diameter (cm) | 0.895 | |||
≤3.0 | 138(86.3) | 100 | 38 | |
3.0< | 22(13.7) | 14 | 8 | |
pN | 0.1706 | |||
N0 | 141(88.1) | 103 | 38 | |
N1/N2 | 19(11.9) | 11 | 8 | |
Pleural involvement | 0.2413 | |||
Negative | 122(76.2) | 93 | 29 | |
Positive | 8(23.8) | 21 | 17 | |
Lymphovascular involvement | 0.0025 | |||
Negative | 135(84.4) | 98 | 37 | |
Positive | 25(15.6) | 16 | 9 | |
Vascular involvement | 0.0126 | |||
Negative | 120(75.0) | 93 | 27 | |
Positive | 40(25.0) | 21 | 19 | |
p-stage | 0.2611 | |||
IA | 108(67.5) | 82(71.9) | 26(56.5) | |
IB | 30(18.8) | 20 | 10 | |
IIA | 10(6.3) | 6 | 4 | |
IIB | 3(1.8) | 1 | 2 | |
IIIA | 9(5.6) | 5 | 4 | |
Recurrence | 160(100) | 12 | 10 | 0.0623 |
Death | 160(100) | 6 | 9 | 0.005 |
B1eeding (g) | 160(100) | 118.1 ± 154.3 | 321.6 ± 352.4 | <0.0001 |
Surgery time (min.) | 160(100) | 198.3 ± 50.2 | 205.1 ± 60.9 | 0.4662 |